FGFR3 mutation causes abnormal membranous ossification in achondroplasia

FGFR3 mutation causes abnormal membranous ossification in achondroplasia

FGFR3 gain-of-function mutations lead to both chondrodysplasias and craniosynostoses. Achondroplasia (ACH), the most frequent dwarfism, is due to an FGFR3-activating mutation which results in impaired endochondral ossification. The effects of the mutation on membranous ossification are unknown. Fgfr...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autors principals:	Federico Di Rocco, Martin Biosse Duplan, Yann Heuzé, Nabil Kaci, Davide Komla‐Ebri, Arnold Münnich, Emilie Mugniery, Catherine Benoist-Lasselin, Laurence Legeai‐Mallet
Format:	Artigo
Idioma:	anglès
Publicat:	2014
Accés en línia:	https://doi.org/10.1093/hmg/ddu004
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Meckel’s and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandible
per: Biosse Duplan, Martin, et al.
Publicat: (2016)

Meckel’s and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandible
per: Martin Biosse Duplan, et al.
Publicat: (2016)

Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia
per: Florence Lorget, et al.
Publicat: (2012)

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model
per: Komla-Ebri, Davide, et al.
Publicat: (2016)

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model
per: Davide Komla‐Ebri, et al.
Publicat: (2016)

Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia
per: Lorget, Florence, et al.
Publicat: (2012)

Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia
per: Ludovic Martin, et al.
Publicat: (2017)

Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification
per: Anne‐Lise Delezoide, et al.
Publicat: (1998)

Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice
per: Léa Loisay, et al.
Publicat: (2023)

An Fgfr3-activating mutation in immature murine osteoblasts affects the appendicular and craniofacial skeleton
per: Biosse Duplan, Martin, et al.
Publicat: (2021)

Theobroma cacao improves bone growth by modulating defective ciliogenesis in a mouse model of achondroplasia
per: Martin, Ludovic, et al.
Publicat: (2022)

Achondroplasia: Development, Pathogenesis, and Therapy
per: Ornitz, David M., et al.
Publicat: (2017)

Achondroplasia: Development, pathogenesis, and therapy
per: David M. Ornitz, et al.
Publicat: (2016)

Fibroblast Growth Factor Receptor 3 Mutations Promote Apoptosis but Do Not Alter Chondrocyte Proliferation in Thanatophoric Dysplasia
per: Laurence Legeai‐Mallet, et al.
Publicat: (1998)

Novel therapeutic approaches for the treatment of achondroplasia
per: Laurence Legeai‐Mallet, et al.
Publicat: (2020)

New Insight on FGFR3-Related Chondrodysplasias Molecular Physiopathology Revealed by Human Chondrocyte Gene Expression Profiling
per: Schibler, Laurent, et al.
Publicat: (2009)

SUN-101 Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia
per: Demuynck, Benoit, et al.
Publicat: (2020)

Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia
per: S. Heuertz, et al.
Publicat: (2006)

FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model
per: Cornille, Maxence, et al.
Publicat: (2022)

Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth
per: Shuhaibar, Leia C., et al.
Publicat: (2021)

Achondroplasia manifesting as enchondromatosis and ossification of the spinal ligaments: a case report
per: Al Kaissi, Ali, et al.
Publicat: (2008)

Achondroplasia is defined by recurrent G380R mutations of FGFR3.
per: Bellus, G A, et al.
Publicat: (1995)

FGFR3 Heterodimerization in Achondroplasia, the Most Common Form of Human Dwarfism
per: He, Lijuan, et al.
Publicat: (2011)

Novel Phenotype of Achondroplasia due to Biallelic FGFR3 Pathogenic Variants
per: Chang, Irene J., et al.
Publicat: (2018)

Macrocerebellum in Achondroplasia: A Further CNS Manifestation of FGFR3 Mutations?
per: Pascoe, H.M., et al.
Publicat: (2020)

Evaluation of FGFR inhibitor ASP5878 as a drug candidate for achondroplasia
per: Ozaki, Tomonori, et al.
Publicat: (2020)

Molecular Confirmation of G1138A Mutation in FGFR gene in Achondroplasia
per: Khanal, Shyam Bahadur, et al.
Publicat: (2018)

ADAMTS10 Mutations in Autosomal Recessive Weill-Marchesani Syndrome
per: Dagoneau, Nathalie, et al.
Publicat: (2004)

ADAMTS10 Mutations in Autosomal Recessive Weill-Marchesani Syndrome
per: Nathalie Dagoneau, et al.
Publicat: (2004)

Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
per: François Rousseau, et al.
Publicat: (1996)

Parathyroid Hormone Receptor Type 1/Indian Hedgehog Expression Is Preserved in the Growth Plate of Human Fetuses Affected with Fibroblast Growth Factor Receptor Type 3 Activating Mutations
per: Cormier, Sarah, et al.
Publicat: (2002)

Growth charts in FGFR2- and FGFR3-related faciocraniosynostoses
per: Ea, Caroline, et al.
Publicat: (2022)

Congenital lumbar spinal stenosis with ossification of the ligamentum flavum in achondroplasia: a case report
per: Saito, Kimio, et al.
Publicat: (2014)

Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
per: Saint-Laurent, Celine, et al.
Publicat: (2018)

Snail1 Is a Transcriptional Effector of FGFR3 Signaling during Chondrogenesis and Achondroplasias
per: Cristina A. de Frutos, et al.
Publicat: (2007)

Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function
per: Meyer, April N., et al.
Publicat: (2020)

Effect of the G375C and G346E Achondroplasia Mutations on FGFR3 Activation
per: He, Lijuan, et al.
Publicat: (2012)

Meclozine Facilitates Proliferation and Differentiation of Chondrocytes by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia
per: Matsushita, Masaki, et al.
Publicat: (2013)

Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia
per: Lee, Yi-Ching, et al.
Publicat: (2017)

Meclozine Facilitates Proliferation and Differentiation of Chondrocytes by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia
per: Masaki Matsushita, et al.
Publicat: (2013)